TrialEBioMedicine2019

Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study.

Ellie Hershberger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.